Evidence map›Paper›PMID 34252224›Full record

ArticleExperimental dermatology2021

Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology.

Angelique N Voorberg, Hanna Niehues, Jart A F Oosterhaven, Geertruida L E Romeijn, Ivonne M J J van Vlijmen-Willems, Piet E J van Erp, Thomas H A Ederveen, Patrick L J M Zeeuwen, Marie L A Schuttelaar

Open access · hybridAbstract read
In one paragraph

Article in Experimental dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Chronic Hand Eczema.American journal of clinical dermatology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. A systematic analysis ofFrontiers in genetics · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Angelique N VoorbergDepartment of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0001-5061-894X
Hanna NiehuesDepartment of Dermatology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen Medical Center (Radboudumc), Nijmegen, The Netherlands.ORCID 0000-0002-6954-6955
Jart A F OosterhavenDepartment of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0001-7214-7528
Geertruida L E RomeijnDepartment of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0003-4408-8596
Ivonne M J J van Vlijmen-WillemsDepartment of Dermatology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen Medical Center (Radboudumc), Nijmegen, The Netherlands.ORCID 0000-0002-3522-2573
Piet E J van ErpDepartment of Dermatology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen Medical Center (Radboudumc), Nijmegen, The Netherlands.ORCID 0000-0002-6955-8817
Thomas H A EderveenCenter for Molecular and Biomolecular Informatics, RIMLS, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0003-0068-1275
Patrick L J M ZeeuwenDepartment of Dermatology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen Medical Center (Radboudumc), Nijmegen, The Netherlands.ORCID 0000-0002-6878-2438
Marie L A SchuttelaarDepartment of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-0766-4382
Radboud University Nijmegen · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hand eczema is a common inflammatory skin condition of the hands whose pathogenesis is largely unknown. More insight and knowledge of the disease on a more fundamental level might lead to a better understanding of the biological processes involved, which could provide possible new treatment strategies. We aimed to profile the transcriptome of lesional palmar epidermal skin of patients suffering from vesicular hand eczema using RNA-sequencing. RNA-sequencing was performed to identify differentially expressed genes in lesional vs. non-lesional palmar epidermal skin from a group of patients with vesicular hand eczema compared to healthy controls. Comprehensive real-time quantitative PCR analyses and immunohistochemistry were used for validation of candidate genes and protein profiles for vesicular hand eczema. Overall, a significant and high expression of genes/proteins involved in keratinocyte host defense and inflammation was found in lesional skin. Furthermore, we detected several molecules, both up or downregulated in lesional skin, which are involved in epidermal differentiation. Immune signalling genes were found to be upregulated in lesional skin, albeit with relatively low expression levels. Non-lesional patient skin showed no significant differences compared to healthy control skin. Lesional vesicular hand eczema skin shows a distinct expression profile compared to non-lesional skin and healthy control skin. Notably, the overall results indicate a large overlap between vesicular hand eczema and earlier reported atopic dermatitis lesional transcriptome profiles, which suggests that treatments for atopic dermatitis could also be effective in (vesicular) hand eczema.

Indexed as

AdultAgedCase-Control StudiesEczemaFemaleHand DermatosesHumansMaleMiddle AgedTranscriptomeYoung Adultbarrier functionhand eczemapathophysiologyRNA sequencingtranscriptomics

Identifiers

PMID34252224
PMCPMC8596617
OpenAlexW3181970749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.